UK university test COVID-19 vaccine derived from aborted fetal cell line in Africa, Brazil
Starting this past Wednesday, approximately 2000 volunteers in South Africa ranging in age from 18 to 65 began to receive the trial vaccine known commercially as AZD1222
•